Matthew R. Mysliwiec, Ph.D.

2009 University of Wisconsin, Madison, Madison, WI 
Molecular Biology
"Matthew Mysliwiec"


Sign in to add mentor
Youngsook Lee grad student 2009 UW Madison
 (The roles of Jarid2/Jumonji in cardiac development.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cho E, Mysliwiec MR, Carlson CD, et al. (2018) Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development. The Journal of Biological Chemistry
Brody MJ, Cho E, Mysliwiec MR, et al. (2013) Lrrc10 is a novel cardiac-specific target gene of Nkx2-5 and GATA4. Journal of Molecular and Cellular Cardiology. 62: 237-46
Mysliwiec MR, Carlson CD, Tietjen J, et al. (2012) Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart Journal of Biological Chemistry. 287: 1235-1241
Mejetta S, Morey L, Pascual G, et al. (2011) Jarid2 regulates mouse epidermal stem cell activation and differentiation. The Embo Journal. 30: 3635-46
Zhang Z, Jones A, Sun CW, et al. (2011) PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells (Dayton, Ohio). 29: 229-40
Mysliwiec MR, Bresnick EH, Lee Y. (2011) Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. The Journal of Biological Chemistry. 286: 17193-204
Shen X, Kim W, Fujiwara Y, et al. (2009) Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell. 139: 1303-14
Mysliwiec MR, Kim TG, Lee Y. (2007) Characterization of zinc finger protein 496 that interacts with Jumonji/Jarid2. Febs Letters. 581: 2633-40
Mysliwiec MR, Chen J, Powers PA, et al. (2006) Generation of a conditional null allele of jumonji. Genesis (New York, N.Y. : 2000). 44: 407-11
Kim TG, Jung J, Mysliwiec MR, et al. (2005) Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity. Biochemical and Biophysical Research Communications. 329: 544-53
See more...